Dr Joleen Hubbard discusses non-surgical management of early stage rectal cancer
Oncology
Non-surgical management of early stage rectal cancer
Publication Date
Sep 2021
Dr Joleen Hubbard is Deputy Director of Clinical Research and Academic Affairs for the Allina Health Cancer Institute in Minneapolis, Minnesota. She was previously Assistant Professor of Medical Oncology at Mayo Clinic. She completed medical school and residency at the University of Minnesota and haematology/oncology training at Mayo Clinic, Rochester, Minnesota. Dr Hubbard specialises in the treatment of gastrointestinal cancers, focusing on colorectal cancer. Dr Hubbard is the PI of several phase I clinical trials, investigating novel agents for gastrointestinal cancers. Her research interests also include geriatric oncology with a special interest in clinical and biologic markers of frailty. She serves as a member of the Cancer in the Elderly, as well as the Health Reported Outcomes and Translational Research committees for the North American Alliance of Clinical Trials in Oncology Network.
Assoc. Prof. Joleen Hubbard has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
Advisory boards: Bayer, Merck, BeiGene, Incyte
Research funding to institution: Merck, Boston Biomedical, Treos Bio, Senhwa Pharmaceuticals, Bayer, Incyte, TriOncology, Seattle Genetics, Hutchison MediPharma, Pionyr Immunotherapeutics, Trovogene, G1 Therapeutics, Roche
Programme summary
Duration 5 MIN
Downloadable resources Yes-
Download the slides
-
Language(s)
Share this programme
Brought to you by
GI CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from Bayer, Ipsen, BeiGene Europe and Pierre Fabre.
Meet the experts
Other programmes of interest
Animated Video
Oncology
Precision oncology in prostate and gastric cancer: tips for optimal genomic testing
From sample collection through to diagnostic modalities
Experts
Dr Alexander Wyatt, Prof. Frédéric BibeauEndorsed by
-
Downloadable
Resources -
4 MIN
-
Dec 2024
Podcast
Episode
2
of 2
Oncology
HCC podcast series part 2: 2nd line treatment in advanced HCC and when to switch
Medical experts discuss how to approach sequencing in clinical practice
Experts
Prof. Arndt Vogel, Dr Lorenza Rimassa, Oncology Brothers (Moderators)Endorsed by
-
Downloadable
Resources -
26 MIN
-
Dec 2024
Podcast
Oncology
Testing to treatment of BRAF-mutant metastatic NSCLC
Medical experts share their insights on testing and treatment
Experts
Prof. David Planchard, Dr Federico Cappuzzo-
Downloadable
Resources -
23 MIN
-
Nov 2024
Podcast
Episode
1
of 2
Oncology
HCC podcast series part 1: The use of IO in unresectable HCC
Medical experts discuss safety and efficacy of IO and IO combinations, clinical trial data, and best practice
Experts
Dr Rachna Shroff, Oncology Brothers (Moderators)Endorsed by
-
Downloadable
Resources -
23 MIN
-
Nov 2024
Video
Oncology
The emerging role of artificial intelligence in precision oncology
Expert opinion on the clinical application of artificial intelligence (AI)
Experts
Prof. Albrecht Stenzinger-
Downloadable
Resources -
6 MIN
-
Nov 2024
Podcast
Oncology
BRAF-mutated CRC: from testing to treatment
Medical experts share insights and review key clinical trials
Experts
Prof. Sebastian Stintzing, Dr Thomas WinderEndorsed by
-
Downloadable
Resources -
25 MIN
-
Nov 2024
